Magnavita, Jeffrey J – Trademark Portfolio
Entity Type: 01
Magnavita, Jeffrey J holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PSYCHTRENDS, PSYCHINCUBATOR, and STRATEGIC PSYCHOTHERAPEUTICS. The owner is based in South Glastonbury, CT.
272 Grindle Brook Road
South Glastonbury, CT 06073
Showing of trademarks Trademarks
Trademark Classifications
Magnavita, Jeffrey J's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Magnavita, Jeffrey J have?
Magnavita, Jeffrey J has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 2 cancelled.
What trademark classes does Magnavita, Jeffrey J file in?
Magnavita, Jeffrey J files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 38 (Telecommunications). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Magnavita, Jeffrey J's most well-known trademarks?
Magnavita, Jeffrey J's registered trademark portfolio includes well-known marks such as PSYCHTRENDS, PSYCHINCUBATOR, and STRATEGIC PSYCHOTHERAPEUTICS. These are among 3 currently registered trademarks in the portfolio.
What is Magnavita, Jeffrey J's trademark registration success rate?
Magnavita, Jeffrey J has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.